TransMedics (TMDX) closed the last trading session at $143.80, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $181.89 indicates a 26.5% upside potential. The average comprises nine short-term price targets ranging from a low of $153 to a high of $208, with a standard deviation of $17.60. While the lowest estimate indicates an increase of 6.4% from the current price le ...